D-0551-2026 Class III Ongoing
FDA drug recall D-0551-2026 was initiated by AbbVie Inc. on May 18, 2026 and is designated Class III. Reason for recall: Failed Stability Specifications The recall status is ongoing. Affected quantity: 2,736 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- June 3, 2026
- Initiation Date
- May 18, 2026
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,736 bottles
Product Description
PRED MILD, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Sterile, Rx only, Allergen, Inc., an AbbVie company, North Chicago, IL 60064, Product of France, NDC 11980-174-10.
Reason for Recall
Failed Stability Specifications
Distribution Pattern
US Nationwide.
Code Information
Lot # 402805, 407596, Exp Date: 08/2026.